Additionally, EFHD1 overexpression reduced nuclear YAP1, nuclear TAZ, and TEAD1 levels, thereby preventing YAP1/TAZ nuclear translocation and interaction with TEAD1, a key process in tumor progression. This evidence concerns the gene EFHD1 and neoplasm.